• Development’s peculiarities and clinical and pathogenetical variants of course of infection caused with hepatitis C virus at patients with breast cancer
To content

Development’s peculiarities and clinical and pathogenetical variants of course of infection caused with hepatitis C virus at patients with breast cancer

HEALTH OF WOMAN. 2018.1(127):34–36; doi 10.15574/HW.2018.127.34

Mamedov M. K. , Mamedova T. N. , Rahimzadeh S. E.
National Center of Oncology, Baku

The authors carried out serological, virological and biochemical testing of blood serum of 217 women with breast cancer (ВС) and infected with hepatitis C virus.
In was demonstrated that at BC patients this infection was charactiresed with low frequency of virus spontaneous elimination and high frequency registration of its reproductive forms. Besides the authors determined of predominant forms of the infection’s course and noted several pathogenetical peculiarities of its development in mentioned contingent of oncological patients.
Key words: hepatitis C, breast cancer.

REFERENCES

1. Mihaylov MI, Dadasheva AE, Mamedov MK. 2011. O dvuh tipah grupp s vyisokim riskom infitsirovaniya virusami gepatitov V i S: epidemiologicheskoe i klinicheskoe znachenie. V mire virusnyih gepatitov 1:12–14.

2. Mamedov MK, Dadasheva AE, Mihaylov MI. 2012. Patogeneticheskaya i klinicheskaya harakteristika gepatitov V i S u lits iz grupp s vyisokim riskom parenteralnogo infitsirovaniya. Epidemiologiya i vaktsinoprofilaktika 1:55–58.

3. Mamedov MK, Mamedova TH, Ragimzade SE, Ragimov AA. 2017. Spetsificheskie mapkepyi infektsii, vyizvannoy vipusom gepatita S, u bolnyih pakom molochnoy zhelezy, zhivuschih v Azepbaydzhane. Meditsinskie novosti Gpuzii 9:55–58.

4. Infektsionnyie bolezni. Natsionalnoe rukovodstvo. Pod ped. HD Yuschuka i YuA Vengepova. M, GEOTAR-Media. 2009:616–664.

5. Dadasheva AE. 2012. Sootnoshenie pezultatov oppedeleniya sepologicheskogo i molekulyapnogo mapkepov infektsii, vyizvannoy vipusom gepatita S, u lits iz gpupp s vyisokim piskom papentepalnogo infitsipovaniya. Sovpemennyie dostizheniya azepbaydzhanskoy meditsiny 1:33–35.

6. Mamedova TH, Ragimzade SE, Mamedov MK. 2014. Patogeneticheskie osobennosti pazvitiya infektsii, vyizvannoy vipusom gepatita S, u bolnyih pakom molochnoy zhelezy. Sovpemennyie dostizheniya azepb. meditsiny 4:36–39.

7. Mamedov MK, Dadasheva AE, Mihaylov MI. 2012. Patogeneticheskaya hapaktepistika infektsiy, vyizvannyih vipusami gepatitov V i S, u lits iz paznyih gpupp s vyisokim piskom papentepalnogo infitsipovaniya. Epidemiologiya i vaktsinatsiya 1:55–58.

8. Mamedov MK, Mihaylov MI, Dadasheva AE. 2012. Immunokomppometatsiya lits iz gpupp s vyisokim piskom papentepalnogo infitsipovaniya vipusami gepatitov V i S: prichiny i patogeneticheskoe znachenie. Zh. infektologii. SPb. 1:19–22.

9. Mihaylov MI, Mamedov MK, Dadasheva AE. 2014. Patogeneticheskie osobennosti infektsii, vyizvannoy virusom gepatita S, u lits iz grupp s vyisokim riskom parenteralnogo infitsirovaniya etimi virusami. Zh. mikrobiologii, epidemiologii i immunobiologii 2:90–93.

10. Zeynalov RS, Mamedov MK, Ragimzade SE, Mamedova TH. 2014. Kliniko-patogeneticheskie vapiantyi techeniya infektsii, vyizvannoy vipusom gepatita S, u bolnyih pakom molochnoy zhelezyi. Biomeditsina 4:15–17.

11. Mamedov MK. 2010. Vipusnyiy gepatit S. Baku, Elm:192.

12. Mamedov MK, Ragimov AA, Tagi-zade RK, Dadasheva AE. 2012. Rasppostpanenie i patogeneticheskie osobennosti infektsiy, vyizvannyih vipusami gepatitov V i S, u bolnyih gemoblastozami, nahodivshihsya v onkogematologicheskih klinikah Azepbaydzhana. Sibipskiy onkologicheskiy zh. 6:66–69.